XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2

Licenses, Asset Acquisitions and Contingent Consideration (Tables)

9 Months Ended

Sep. 30, 2020

Business Combinations [Abstract]

Schedule of IPR&D Expense

The Company recorded the following IPR&D expense on the condensed consolidated statements of operations (in thousands):

			Three months ended September 30,												Nine months ended September 30,
			2020						2019						2020						2019
GB001			$	—					$	—					$	—					$	—
GB002			—						—						—						—
GB004			275						—						15,275						—
GB1275			—						—						—						1,000
Other Programs			—						—						2,805						1,000
Total in process research and development			$	275					$	—					$	18,080					$	2,000

X

- Definition

In process research and development expenses.

+ References

No definition available.

+ Details

Name:	goss_InProcessResearchAndDevelopmentExpensesTableTextBlock
Namespace Prefix:	goss_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration